Annual Revenue
$64.70 M
-$65.79 M-50.42%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual revenue is $64.70 million, with the most recent change of -$65.79 million (-50.42%) on December 31, 2023.
Performance
PSTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$71.75 M
+$45.77 M+176.24%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly revenue is $71.75 million, with the most recent change of +$45.77 million (+176.24%) on September 30, 2024.
- Over the past year, PSTX quarterly revenue has increased by +$45.77 million (+176.24%).
Performance
PSTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$150.86 M
+$62.40 M+70.53%
September 30, 2024
Summary
- As of February 7, 2025, PSTX TTM revenue is $150.86 million, with the most recent change of +$62.40 million (+70.53%) on September 30, 2024.
- Over the past year, PSTX TTM revenue has increased by +$62.40 million (+70.53%).
Performance
PSTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
PSTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -50.4% | +176.2% | +70.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PSTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.4% | -51.7% | -38.3% | -98.0% | -3.7% | -79.3% |
| 5 y | 5-year | -50.4% | -51.7% | -38.3% | -98.0% | -3.7% | -79.3% |
| alltime | all time | -50.4% | -95.4% | -38.3% | -98.0% | -3.7% | -79.3% |
Poseida Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $71.75 M(+176.2%) | $150.86 M(+70.5%) |
| Jun 2024 | - | $25.97 M(-7.7%) | $88.46 M(+7.2%) |
| Mar 2024 | - | $28.14 M(+12.6%) | $82.50 M(+27.5%) |
| Dec 2023 | $64.70 M | $25.00 M(+167.3%) | $64.70 M(+30.0%) |
| Sep 2023 | - | $9.35 M(-53.3%) | $49.76 M(-68.2%) |
| Jun 2023 | - | $20.01 M(+93.5%) | $156.71 M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $10.34 M(+2.9%) | $139.40 M(+6.8%) |
| Dec 2022 | $130.49 M(+317.7%) | $10.05 M(-91.4%) | $130.49 M(-14.0%) |
| Sep 2022 | - | $116.31 M(+4207.6%) | $151.68 M(+328.8%) |
| Jun 2022 | - | $2.70 M(+88.2%) | $35.37 M(+8.3%) |
| Mar 2022 | - | $1.44 M(-95.4%) | $32.67 M(+4.6%) |
| Dec 2021 | $31.24 M(+946.5%) | $31.24 M | $31.24 M |
| Dec 2017 | $2.98 M | - | - |
FAQ
- What is Poseida Therapeutics annual revenue?
- What is the all time high annual revenue for Poseida Therapeutics?
- What is Poseida Therapeutics annual revenue year-on-year change?
- What is Poseida Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly revenue year-on-year change?
- What is Poseida Therapeutics TTM revenue?
- What is the all time high TTM revenue for Poseida Therapeutics?
- What is Poseida Therapeutics TTM revenue year-on-year change?
What is Poseida Therapeutics annual revenue?
The current annual revenue of PSTX is $64.70 M
What is the all time high annual revenue for Poseida Therapeutics?
Poseida Therapeutics all-time high annual revenue is $130.49 M
What is Poseida Therapeutics annual revenue year-on-year change?
Over the past year, PSTX annual revenue has changed by -$65.79 M (-50.42%)
What is Poseida Therapeutics quarterly revenue?
The current quarterly revenue of PSTX is $71.75 M
What is the all time high quarterly revenue for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly revenue is $116.31 M
What is Poseida Therapeutics quarterly revenue year-on-year change?
Over the past year, PSTX quarterly revenue has changed by +$45.77 M (+176.24%)
What is Poseida Therapeutics TTM revenue?
The current TTM revenue of PSTX is $150.86 M
What is the all time high TTM revenue for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM revenue is $156.71 M
What is Poseida Therapeutics TTM revenue year-on-year change?
Over the past year, PSTX TTM revenue has changed by +$62.40 M (+70.53%)